Maged Shenouda Relmada Therapeutics, Inc. (RLMD) insider trading activity

Maged Shenouda is Chief Financial Officer of RELMADA THERAPEUTICS, INC.. Currently has a direct ownership of 800,000 shares of RLMD, which is worth approximately $3.16 Million. The most recent transaction as insider was on Feb 02, 2021, when has been sold 3,200 shares (Common Stock) at a price of $3.24 per share, resulting in proceeds of $10,368. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 800K

177.46% 3M change

805.64% 12M change

Total Value Held $3.16 Million

Maged Shenouda Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 02 2021	BUY Exercise of conversion of derivative security	$10,368 $3.24 p/Share	3,200 Added 37.09%	5,428 Common Stock
Jan 27 2021	SELL Open market or private sale	$96,030 $32.01 p/Share	3,000 Reduced 57.38%	2,228 Common Stock
Jan 27 2021	BUY Exercise of conversion of derivative security	$9,720 $3.24 p/Share	3,000 Added 36.46%	5,228 Common Stock
Jan 26 2021	SELL Open market or private sale	$21,342 $35.16 p/Share	607 Reduced 21.41%	2,228 Common Stock
Jan 25 2021	SELL Open market or private sale	$45,146 $35.27 p/Share	1,280 Reduced 31.11%	2,835 Common Stock
Jan 22 2021	SELL Open market or private sale	$75,603 $35.78 p/Share	2,113 Reduced 33.93%	4,115 Common Stock
Jan 22 2021	BUY Exercise of conversion of derivative security	$1,296,000 $324.0 p/Share	4,000 Added 39.11%	6,228 Common Stock

Maged Shenouda

Chief Financial Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLMD shares.

Notify only if

Value

Insider Trading

Get notified when an Relmada Therapeutics, Inc. insider buys or sells RLMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to RELMADA THERAPEUTICS, INC.

Track Activities on RLMD

Account